| Style | Citing Format |
|---|---|
| MLA | Rarani F Z, Sharifi M, Rashidi B. "Serum Reproductive Hormone Profiles and Endometrial Expression of Mir-16-5P, Vegf Gene, and Protein, and Cd31-Positive Cells Following Progesterone and Egcg Administration." Advanced Biomedical Research, vol. 14, no. 1, 2025, pp. -. |
| APA | Rarani F Z, Sharifi M, Rashidi B (2025). Serum Reproductive Hormone Profiles and Endometrial Expression of Mir-16-5P, Vegf Gene, and Protein, and Cd31-Positive Cells Following Progesterone and Egcg Administration. Advanced Biomedical Research, 14(1), -. |
| Chicago | Rarani F Z, Sharifi M, Rashidi B. "Serum Reproductive Hormone Profiles and Endometrial Expression of Mir-16-5P, Vegf Gene, and Protein, and Cd31-Positive Cells Following Progesterone and Egcg Administration." Advanced Biomedical Research 14, no. 1 (2025): -. |
| Harvard | Rarani F Z, Sharifi M, Rashidi B (2025) 'Serum Reproductive Hormone Profiles and Endometrial Expression of Mir-16-5P, Vegf Gene, and Protein, and Cd31-Positive Cells Following Progesterone and Egcg Administration', Advanced Biomedical Research, 14(1), pp. -. |
| Vancouver | Rarani F Z, Sharifi M, Rashidi B. Serum Reproductive Hormone Profiles and Endometrial Expression of Mir-16-5P, Vegf Gene, and Protein, and Cd31-Positive Cells Following Progesterone and Egcg Administration. Advanced Biomedical Research. 2025;14(1):-. |
| BibTex | @article{ author = {Rarani F Z and Sharifi M and Rashidi B}, title = {Serum Reproductive Hormone Profiles and Endometrial Expression of Mir-16-5P, Vegf Gene, and Protein, and Cd31-Positive Cells Following Progesterone and Egcg Administration}, journal = {Advanced Biomedical Research}, volume = {14}, number = {1}, pages = {-}, year = {2025} } |
| RIS | TY - JOUR AU - Rarani F Z AU - Sharifi M AU - Rashidi B TI - Serum Reproductive Hormone Profiles and Endometrial Expression of Mir-16-5P, Vegf Gene, and Protein, and Cd31-Positive Cells Following Progesterone and Egcg Administration JO - Advanced Biomedical Research VL - 14 IS - 1 SP - EP - PY - 2025 ER - |